Google+ Facebook Twitter Twitter

Sebia enters agreement

The test mitigates the potential interference in visualisation of M-proteins in immunofixation electrophoresis caused by DARZALEX. 


DARZALEX is a human monoclonal antibody targeting CD38 that provides superior clinical benefit to monotherapy in heavily pre-treated multiple myeloma (MM) patients and when combined with standard of care regimens for the treatment of MM.

Related Articles

Congress update: real science, relevance

Sarah May, Deputy Chief Executive at the IBMS, explains the approach behind this year’s Congress.

X-ray: Shutterstock

How to…monitor a clinical service using audit

Following the completion of a high-quality audit, the team at Manchester Royal Infirmary’s cytology department offer guidance on monitoring a clinical service.

More content at Congress

Sarah May, Deputy Chief Executive at the IBMS, looks at the new sessions that have been added to this year’s Congress.

Journal-based learning: iStock

Journal-based learning exercises May 2017

Journal-based learning exercises for May 2017.  You may complete as many JBL exercises as you wish and you are not restricted by specialty.